IVD Medical Holding Management
Management criteria checks 4/4
IVD Medical Holding's CEO is Kuk Sing Ho, appointed in Jun 2019, has a tenure of 5.5 years. total yearly compensation is CN¥3.70M, comprised of 99.8% salary and 0.2% bonuses, including company stock and options. directly owns 10.8% of the company’s shares, worth HK$280.83M. The average tenure of the management team and the board of directors is 5.5 years and 3.2 years respectively.
Key information
Kuk Sing Ho
Chief executive officer
CN¥3.7m
Total compensation
| CEO salary percentage | 99.8% |
| CEO tenure | 5.5yrs |
| CEO ownership | 10.8% |
| Management average tenure | 5.5yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Dec 12
IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up
Oct 14Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings
Sep 27IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings
Aug 17Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding
Jun 07These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely
May 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 25IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 03IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings
Mar 30IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year
Mar 20If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity
Mar 06IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Feb 08Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Oct 22IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher
Oct 01IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
Aug 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556
Mar 22Returns At IVD Medical Holding (HKG:1931) Are On The Way Up
Feb 16Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?
Oct 16Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)
Sep 28IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet
May 16IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053
Apr 14IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 23IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Mar 16IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital
Jul 30These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well
May 04There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital
Apr 20IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year
Mar 05Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 15
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like
Jan 31A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Jan 16Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?
Jan 01How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?
Dec 17Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?
Dec 02IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.
Nov 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥260m |
| Mar 31 2024 | n/a | n/a | CN¥249m |
| Dec 31 2023 | CN¥4m | CN¥4m | CN¥238m |
| Sep 30 2023 | n/a | n/a | CN¥235m |
| Jun 30 2023 | n/a | n/a | CN¥232m |
| Mar 31 2023 | n/a | n/a | CN¥221m |
| Dec 31 2022 | CN¥5m | CN¥4m | CN¥210m |
| Sep 30 2022 | n/a | n/a | CN¥193m |
| Jun 30 2022 | n/a | n/a | CN¥177m |
| Mar 31 2022 | n/a | n/a | CN¥176m |
| Dec 31 2021 | CN¥4m | CN¥4m | CN¥175m |
Compensation vs Market: Kuk Sing's total compensation ($USD507.12K) is about average for companies of similar size in the Hong Kong market ($USD393.49K).
Compensation vs Earnings: Kuk Sing's compensation has been consistent with company performance over the past year.
CEO
Kuk Sing Ho (64 yo)
5.5yrs
Tenure
CN¥3,700,000
Compensation
Mr. Ho Kuk Sing serves as Executive Director, Chairman of the Board and Chief Executive Officer at IVD Medical Holding Limited since June 21, 2019. He was Director of IVD Medical Holding Limited since May...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 5.5yrs | CN¥3.70m | 10.8% HK$ 280.8m | |
| GM & Executive Director | 5.5yrs | CN¥2.16m | 6.93% HK$ 180.3m | |
| CFO, Company Secretary & Executive Director | less than a year | no data | no data | |
| Executive Director | less than a year | no data | no data | |
| Financial Controller | 8.8yrs | no data | no data |
5.5yrs
Average Tenure
47yo
Average Age
Experienced Management: 1931's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 8.6yrs | CN¥3.70m | 10.8% HK$ 280.8m | |
| GM & Executive Director | 8.9yrs | CN¥2.16m | 6.93% HK$ 180.3m | |
| CFO, Company Secretary & Executive Director | less than a year | no data | no data | |
| Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 5.5yrs | CN¥120.00k | no data | |
| Independent Non-Executive Director | 5.5yrs | CN¥120.00k | no data | |
| Non-Executive Director | 3.2yrs | no data | no data | |
| Non-executive Director | less than a year | no data | no data |
3.2yrs
Average Tenure
51yo
Average Age
Experienced Board: 1931's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 02:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IVD Medical Holding Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue-Kwong Lui | Jefferies LLC |